Serotonin Pharmaceuticals Llp - Due diligence report

A 360° intelligence report on Serotonin Pharmaceuticals Llp: trust score, financial health, credit view, compliance, directors, growth and d…

2017-12-07 Ahmedabad, Gujarat Active
Share
Connect MCP
SP Serotonin Pharmaceuticals Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Serotonin Pharmaceuticals Llp — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Serotonin Pharmaceuticals Llp is assessed as Low Risk with a Trust Score of 88/100. Serotonin Pharmaceuticals Llp is an active limited liability partnership incorporated in 2017, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.

Report generated on 13 Oct 2026 from the latest processed filings. Serotonin Pharmaceuticals Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SWEETY DHARMESH PATEL 01234567 Director 01/04/2018 6 yrs Approved
SULBHA RAJESHKUMAR MANIAR 01234567 Director 01/04/2018 6 yrs Approved
VIVEK SANATKUMAR DOSHI 01234567 Director 01/04/2018 6 yrs Approved
PRADEEP BHIKHALAL VAGHASIYA 01234567 Director 01/04/2018 6 yrs Approved
ASHISH MAHESHBHAI PANDYA 01234567 Director 01/04/2018 6 yrs Approved
RAHUL VIRJIBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
DEEPA PRADEEPBHAI VAGHASIYA 01234567 Director 01/04/2018 6 yrs Approved
HIMANSHU JITENDRAKUMAR DESAI 01234567 Director 01/04/2018 6 yrs Approved
BRIJESH MAHESHBHAI PANDYA 01234567 Director 01/04/2018 6 yrs Approved
  • 9 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Operating for 8 years.
Active GST registration(s).
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • No financials on record - ask for audited statements.
Banker assessment77/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
09 Jan 2019
Director appointed
ASHISH MAHESHBHAI PANDYA (Designated Partner)
Director appointed
RAHUL VIRJIBHAI PATEL (Designated Partner)
Director appointed
DEEPA PRADEEPBHAI VAGHASIYA (Designated Partner)
Director appointed
BRIJESH MAHESHBHAI PANDYA (Designated Partner)
07 Dec 2017
Incorporated
Registered with Roc Ahmedabad
Director appointed
SWEETY DHARMESH PATEL (Designated Partner)
Director appointed
SULBHA RAJESHKUMAR MANIAR (Designated Partner)
Director appointed
VIVEK SANATKUMAR DOSHI (Designated Partner)
Director appointed
PRADEEP BHIKHALAL VAGHASIYA (Designated Partner)
Director appointed
HIMANSHU JITENDRAKUMAR DESAI (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
9 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Divine Commodity And Derivatives Private Limited U51101GJ2004PTC044562 Ahmedabad, Gujarat
Wellknown Organisers Limited U45201GJ1996PLC028725 Ahmedabad, Gujarat
Solar-Polar India Private Limited U29308GJ2021PTC123945 Ahmedabad, Gujarat
Parcotic Healthcare Private Limited U24230GJ2019PTC110855 Ahmedabad, Gujarat
MEGHA OVERSEAS LLP AAH-4237 Ahmedabad, Gujarat
Suvik Communications Private Limited U51506GJ1981PTC004882 Ahmedabad, Gujarat
Medionus Health Private Limited U85300GJ2018PTC104732 Ahmedabad, Gujarat
Techeva Technology Private Limited U74999GJ2020PTC115598 Ahmedabad, Gujarat
Aashna Securities Private Limited U67120GJ1999PTC036587 Ahmedabad, Gujarat
Galaxy Bearings Limited L29120GJ1990PLC014385 Ahmedabad, Gujarat
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Serotonin Pharmaceuticals Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Serotonin Pharmaceuticals Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Serotonin Pharmaceuticals Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Serotonin Pharmaceuticals Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Serotonin Pharmaceuticals Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Serotonin Pharmaceuticals Llp an active company?

Serotonin Pharmaceuticals Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Serotonin Pharmaceuticals Llp financially healthy?

Processed financial statements are not yet available for Serotonin Pharmaceuticals Llp, so its financial health is unassessed.

Should I do business with Serotonin Pharmaceuticals Llp?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Serotonin Pharmaceuticals Llp?

See the directors and ownership sections above for board and shareholding detail. 9 active director(s) are on record.

Does Serotonin Pharmaceuticals Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Serotonin Pharmaceuticals Llp up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Serotonin Pharmaceuticals Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.